Structure-based virtual screening to get news scaffold inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Letters in Drug Design and Discovery Année : 2016

Structure-based virtual screening to get news scaffold inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis

Résumé

In search of new inhibitors of the Ser/Thr protein kinase PknB from Mycobacterium tuberculosis we carried out a structure-based virtual screening study to identify ATP-competitive inhibitors of this enzyme. These studies point out that N-phenylmethylindole-2-carboxamide is a promising scaffold for the development of new PknB inhibitors. We synthesized a small set of analogue compounds to assess the pharmacophore structural requirements and to optimize the inhibitory activity against PknB. This strategy led to the identification of compound 3, endowed with an IC50 of 20 mu M, which provides a novel scaffold for further improvement of PknB inhibitors.
Fichier principal
Vignette du fichier
LDDD_Collucia_2016_1.pdf (238.63 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01602403 , version 1 (27-05-2020)

Licence

Paternité - Partage selon les Conditions Initiales

Identifiants

Citer

Antonio Coluccia, Giuseppe La Regina, Nathalie Barilone, Maria Natalia Lisa, Andrea Brancale, et al.. Structure-based virtual screening to get news scaffold inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis. Letters in Drug Design and Discovery, 2016, 13 (10), pp.1012-1018. ⟨10.2174/1570180813666160801162204⟩. ⟨hal-01602403⟩
94 Consultations
74 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More